Clinical characteristics and treatment response of chronic disseminated candidiasis in patients with hematological disorders.

Sci Rep · 2025 · PMC12000619 · PMID 40234627

Europe PMC DOI

hedged sentences

0.0540

closest p · 1.1× alpha

0.0800

boldest claim

The sentences

a strong trendP = 0.054so close (0.05 < p ≤ 0.1)

In our research, a strong trend toward CR/PR at 3 months was observed in patients treated with caspofungin (OR = 0.193 (95% CI 0.036–1.030), P = 0.054), while such effects were not demonstrated in patients receiving azoles or amphotericin B.

also in 1,049 other papers

approaching significanceP = 0.080so close (0.05 < p ≤ 0.1)

4 D), and at the initial imaging, the median NLR was 0.555 in treatment failure patients compared to 2.79 in remission patients, with the difference approaching significance ( P = 0.080).

also in 569 other papers

showed a trendno p-value reported

Caspofungin treatment showed a trend towards improving CR/PR rate, while severe neutropenia > 20 days and proven diagnosis were significantly associated with 3-month treatment failure.

also in 13,339 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.